However, Moreno-Mayordomo et al. revealed that the response to therapy with botulinum toxin-A in patients with chronic migraine was associated with single nucleotide polymorphisms located in CALCA or TRPV1 genes related to migraine pathophysiology [24]. Here, TRPV1 is linked to migraine disorder.